Close Menu

NEW YORK – Predictive Oncology said Tuesday that it has reached agreements with investors for a direct offering of 2.2 million shares at $1 per share, for gross proceeds of about $2.2 million. 

The Eagan, Minnesota-based firm also has agreed to issue investors about 1.1 million warrants at the same price per share. These warrants will expire 5.5 years from issuance.

The firm said that it would use the proceeds for working capital.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.